FIRST MANHATTAN CO. LLC. - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 39 filers reported holding OCUPHIRE PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q4 2022$2,118
+111.8%
6000.0%0.00%
Q3 2022$1,0000.0%6000.0%0.00%
Q2 2022$1,0000.0%6000.0%0.00%
Q1 2022$1,000
-50.0%
6000.0%0.00%
Q4 2021$2,000
-33.3%
6000.0%0.00%
Q3 2021$3,0000.0%6000.0%0.00%
Q2 2021$3,0000.0%6000.0%0.00%
Q1 2021$3,0006000.00%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Regency Capital Management Inc.\DE 15,000$79,0000.06%
Ikarian Capital, LLC 119,551$632,0000.05%
NORRIS PERNE & FRENCH LLP/MI 78,909$417,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 23,445$124,0000.02%
Stokes Family Office, LLC 12,120$64,0000.01%
MARSHALL WACE, LLP 329,131$1,738,0000.01%
Cornerstone Capital, Inc. 11,357$60,0000.01%
MCF Advisors LLC 9,499$50,0000.01%
Cutler Group LLC / CA 7,900$41,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 13,389$71,0000.00%
View complete list of OCUPHIRE PHARMA INC shareholders